For bioindustrials to reach their full potential, the costs of biomanufacturing must decrease. The current process of bespoke facility development and specialized financing is not-scalable. In this talk, Synonym will discuss the facility development process and outline strategies to standardize critical project components to lower engineering costs, speed development, and open pathways to lower-cost financing—ultimately enabling scalable impact across the industry.
A presentation by Kelsey Weimer, Director, Strategy & Partnerships, Synonym
Find out more: https://www.synonym.bio/
This presentation was filmed Bio Innovations Midwest in Omaha on 24-25 September 2024. Find out more about the event here: https://bioinnovationsmidwest.com/
